Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Endovascular

Access Closure

Panel Discussion | Vascular Access and Closure-Related Issues

Saturday, March 8, 2025
12:08 PM – 12:25 PM ET

    Panel Moderator(s)

  • Nelson L. Bernardo, MD, FSCAI

    Medical Director
    MedStar Heart and Vascular Institute at MedStar Washington Hospital Center
    Washington, District of Columbia, United States

    Disclosure information not submitted.

  • ME

    Marvin Eng, MD

    Structural Heart Disease Medical Director
    Banner University Medical Center
    Phoenix, Arizona, United States

    Disclosure information not submitted.

  • Walter Tan, MD, MS

    Associate Professor of Medicine
    Wake Forest Univ - Atrium/Advocate/Baptist Health
    Winston Salem, North Carolina, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Herbert D. Aronow, MD, MPH

    Medical Director, Heart & Vascular Services
    Henry Ford Health
    Detroit, Michigan, United States

    Disclosure(s): Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)

  • Isida Byku, MD

    Associate Professor, Structural/Interventional Cardiology
    Emory University Hospital

    Disclosure information not submitted.

  • Jeffrey E. Cohen, MD

    Attending Cardiac Surgeon
    Washington Hospital Center
    Washington , District of Columbia, United States

    Disclosure information not submitted.

  • Ramesh Daggubati, MD, FACC, FSCAI

    Vice Chair of the Department of Cardiology & Chief of Interventional Cardiology
    JW Ruby Memorial Hospital, West Virginia University
    Morgantown, West Virginia, United States

    Disclosure(s): medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Douglas E. Drachman, MD, MSCAI

    Director of Education and Director of Interventional Cardiology Fellowship Program
    Massachusetts General Hospital
    Boston, Massachusetts, United States

    Disclosure(s): No financial relationships to disclose

  • Amir Kaki, MD, FACC, FSCAI

    Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
    Henry Ford St John Hospital
    Birmingham, Michigan, United States

    Disclosure(s): Abiomed Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Venkatesh Ramaiah, MD, FACS

    Chief of Vascular & Endovascular Surgery & Complex Vascular Services at Honor Health. Network Medical Director for Honor Health Vascular Services
    Pulse Cardiovascular Institute
    Scottsdale, Arizona, United States

    Disclosure(s): No financial relationships to disclose

  • Peter A. Soukas, MD, FSCAI

    Director, Vascular Medicine & Interventional PV Lab
    Cardiovascular Institute/ Brown Medical School
    Providence, Rhode Island, United States

    Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); AVS: Grant/Research Support (Ongoing); Bard Peripheral Vascular, Inc.: Grant/Research Support (Terminated); Biotronik: Consultant (Ongoing); Inquis Medical: Grant/Research Support (Ongoing); Micromedical Solutions: Grant/Research Support (Terminated); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Grant/Research Support (Ongoing); R3 Vascular: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); Reva Medical: Grant/Research Support (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoundBite Medical Solutions: Grant/Research Support (Terminated)

  • Michael C. Stoner, MD

    Chief, Division of Vascular Surgery
    University of Rochester
    Rochester, New York, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Herbert D. Aronow, MD, MPH: Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)
Ramesh Daggubati, MD, FACC, FSCAI: medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Douglas E. Drachman, MD, MSCAI: No financial relationships to disclose
Amir Kaki, MD, FACC, FSCAI: Abiomed Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Venkatesh Ramaiah, MD, FACS: No financial relationships to disclose
Peter A. Soukas, MD, FSCAI: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); AVS: Grant/Research Support (Ongoing); Bard Peripheral Vascular, Inc.: Grant/Research Support (Terminated); Biotronik: Consultant (Ongoing); Inquis Medical: Grant/Research Support (Ongoing); Micromedical Solutions: Grant/Research Support (Terminated); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Grant/Research Support (Ongoing); R3 Vascular: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); Reva Medical: Grant/Research Support (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoundBite Medical Solutions: Grant/Research Support (Terminated)
Michael C. Stoner, MD: No financial relationships to disclose